犀牛病毒引起的喘息与易患喘的儿童的喘发育有关
Idun Holmdahl1,2, Sofia Lüning1,2, Sabina Wärnberg Gerdin1,2
1Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Acta paediatrica (Oslo, Norway : 1992)
|February 19, 2024
概括
早期的鼻病毒引起的喘息和过敏敏感性是儿童喘的关键风险因素. 这些因素加上遗传性倾向,大大增加了11岁时患喘的可能性.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 流行病学 流行病学
背景情况:
- 儿童喘是一个重要的公共卫生问题,具有复杂的病因因素.
- 早期的呼吸道感染和过敏敏感性与喘发育有关.
- 了解这些因素的相互作用对于有效的预防和管理至关重要.
研究的目的:
- 调查生命早期由犀牛病毒引起的喘息和过敏敏感化与11岁时喘发展之间的关联.
- 确定导致儿童喘发作的关键风险因素.
- 探索遗传倾向和环境因素在喘病因学中的作用.
主要方法:
- 一组107名患有急性喘息 (6-48个月) 的儿童进行了长达11年的随访.
- 为了进行比较,包括了46个年龄相匹配的健康对照.
- 后勤回归分析用于计算确定风险因素的几率比率 (OR) 和95%置信区间 (CI).
主要成果:
- 62.6%的患有早期喘息的儿童在11岁时患有喘.
- 犀牛病毒感染是唯一与喘风险增加相关的常见病毒 (OR 2.4).
- 父母的喘/过敏遗传 (aOR 3.4) 和2岁时的过敏敏感性 (aOR 3.0) 是显著的危险因素.
- 最高的喘患病率发生在患有犀利病毒引起的喘息和过敏敏感的儿童中.
结论:
- 遗传因素和过敏敏感性在儿童喘发育中起着关键作用.
- 犀牛病毒似乎与遗传倾向的儿童的喘发育有关.
- 早期识别这些风险因素可以为预防喘提供有针对性的干预措施.
更多相关视频
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
285
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


